News in the Life Sciences Industry

Momelotinib regulatory pathway clarity anticipated in Q2 2019 -
- SRA737 Phase 1/2 preliminary clinical data anticipated at the 2019 ASCO Annual Meeting -

TSX:IN
OTCQX:IMLFF

QUEBEC CITY and MYRTLE BEACH, SC, May 8, 2019 /PRNewswire/ - TSO3 Inc. (TSX: TOS), ("TSO(3)" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated April 4, 2019, were... Read more ››

MONTREAL, May 8, 2019 /PRNewswire/ - Optina Diagnostics announces today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its retinal imaging platform (CAPRS(1)/MHRC(2)). Optina Diagnostics' platform uses Artificial Intelligence (AI) to analyze the... Read more ››

HANOI, Vietnam, May 8, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Vietnam's National Cancer Hospital, which is affiliated with the K Hospital, will soon begin treating cancer patients with advanced technology from Elekta. The K hospital has invested in a Leksell Gamma Knife®... Read more ››

LAVAL, QC, May 7, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases... Read more ››

TORONTO, May 7, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced results from the COMMENCE clinical study. The data show that Edwards' bioprosthetic surgical... Read more ››